@FierceBiotech: Novo Nordisk's diabetes combo beats Lantus in Phase III. Report | Follow @FierceBiotech
@JohnCFierce: UPDATED: Patriots owner Kraft teams up on a $30M antibiotics A round for Spero. News | Follow @JohnCFierce
@DamianFierce: $TEVA chief Erez Vigodman signs his letters to $MYL with initials only, such is his commitment to synergies. | Follow @DamianFierce
> Researchers from Massachusetts General Hospital are pressing forward with a Phase II study that will test whether a long-used tuberculosis vaccine can treat Type 1 diabetes. More
> Johnson & Johnson ($JNJ) and partner Genmab have submitted the multiple myeloma treatment daratumumab to the FDA, taking advantage of the agency's breakthrough-therapy program in hopes of a speedy approval. News
Medical Device News
@FierceMedDev: ICYMI Friday: Medtronic aims for diabetic consumer tech in deals with Samsung, Glooko and connected MiniMed clearance. Article | Follow @FierceMedDev
@VarunSaxena2: 'Heart in a Box' for preserving transplanted organs received $20M in funding. Story | Follow @VarunSaxena2
@EmilyWFierce: ICYMI from FiercePharma: NICE sings a different tune for Bayer's prostate cancer drug Xofigo. Story | Follow @EmilyWFierce
> Medtronic touts data in support of FDA approval of the latest MiniMed glucose monitor. Story
> Alibaba founder pumps $142M into Beijing-based devicemaker. Article
Pharma News
@FiercePharma: Are European investors catching on to the value of animal health? FierceAnimalHealth story | Follow @FiercePharma
@EricPFierce: ICYMI from FiercePharmaManufacturing: FDA warning letter says Czech company shipped bacteria contaminated APIs to the U.S. Article | Follow @EricPFierce
@CarlyHFierce: U.K. cost watchdogs boost J&J's Stelara ahead of hefty competition. More | Follow @CarlyHFierce
> Could an $18.9B Shire bid convince Actelion to ditch its independence? Story
> Orphan drugmaker Sobi tells potential buyer to take a walk. Article
Animal Health News
> USDA says deadly avian flu virus on the wane in the Midwest as weather warms. Report
> Nexvet shares rebound on positive data from study of pain drug in cats. Item
> FDA launches safety investigation of controversial raw foods for pets. More
> Cancer immunotherapy tried in pet dogs moves to human trials. Story
> Eli Lilly, Zoetis among stakeholders signing on to White House antibiotics plan. Article
Biotech IT News
> Amazon, Google duke it out for control of cloud genomics. Story
> 10X Genomics poaches David Jaffe from the Broad Institute. Item
> U.K. overrun by requests to opt-out of health data sharing program. Article
> Saama raises $35M to fuel push into life science data analytics. News
> Illumina misses out as U.K. picks interpretation providers for 100K Genomes Project. Report
Pharma Marketing News
> ADA highlights: Novo, Lilly meds top Lantus; Sanofi, AZ tout new combo regimens. More
> Pfizer apologizes to U.K. docs as Lyrica protection campaign hits snag. Report
> AbbVie, J&J gallop toward first-line Imbruvica sales with new survival data. Story
> Never too old to be young, Pfizer says, with new tack on Get Old campaign. Article
> Five digital campaigns that show pharma really can do it. Feature